Table 2. Primary treatment for cT1-4 N0-3,x M0-1,x bladder cancer patients at our hospital from September 2006 until February 2013 in relation to age and comorbidity. Data derived from the Netherlands Cancer Registry.

Overall (n=208)
	Cystectomy	Radiotherapy and/ or chemotherapy	Transurethral resection and/ or intravesical therapy	No treatment	Unknown
N (%)	77 (37)	30 (14)	90 (43)	9 (4)	2 (1)
Age year a (median)	69.0	74.0	74.0	84.0	70.0
Comorbidity score b	≥1.0 in 50% of patients	≥2.0 in 50% of patients	≥1.0 in 50% of patients	≥3.0 in 50% of patients	-
Patients aged ≥ 75 years (n=85)
	Cystectomy	Radiotherapy and/ or chemotherapy	Transurethral resection and/ or intravesical therapy	No treatment	Unknown
N (%)	22 (26)	13 (15)	44 (52)	6 (7)	-
Age year c (median)	77.5	85.0	82.0	87.5
Comorbidity score d	≥2.0 in 50% of patients	≥2.0 in 50% of patients	≥2.0 in 50% of patients	≥2.5 in 50% of patients	-

^aIndependent sample T-test for age at cystectomy vs. radiotherapy and/ or chemotherapy p=0.016;

^bIndependent sample T-test for comorbidity at cystectomy vs. radiotherapy and/ or chemotherapy p=0.008;

^cMann-Whitney U test for age at cystectomy vs. radiotherapy and/ or chemotherapy p<0.001;

^dMann-Whitney U test for comorbidity at cystectomy vs. radiotherapy and/ or chemotherapy p=0.334

Note: Comorbidity was scored for: cardiovascular disease, hypertension, pulmonary disease, diabetes and previous malignancy. If present, 1 point per category was scored. Please note, this is not the Charlson Comorbidity Index Score.